Skip to contentB
Bio Essence Corp
B
BIOEBio Essence Corp Q2 2026 · 10-Q
Revenue$794.71K$794.71K+206.7% vs Q2 2025 Net Income$270.08K$270.08K+351.2% vs Q2 2025 EPS Diluted$0.00$0.00— vs Q2 2025 Gross Profit$470,261+178.8% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bio Essence Corp · CIK 1723059 · Engraved from SEC EDGAR
Operating Cash Flowderived$59,650−64.5% Margins · derivedGross margin59.2%−5.9 pt vs Q2 2025
Operating margin35.1%+11.5 pt vs Q2 2025
Net margin34.0%+10.9 pt vs Q2 2025
ended Jun 30, 2026 · filed Aug 14, 2026 · 45 d after period end